miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
H Tang, C Song, F Ye, G Gao, X Ou… - Journal of cellular …, 2019 - Wiley Online Library
Resistance to trastuzumab remains a major obstacle in HER2‐overexpressing breast cancer
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
H Tang, C Song, F Ye, G Gao, X Ou… - Journal of Cellular and …, 2019 - europepmc.org
Resistance to trastuzumab remains a major obstacle in HER2‐overexpressing breast cancer
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
H Tang, C Song, F Ye, G Gao, X Ou… - Journal of Cellular …, 2019 - search.proquest.com
Resistance to trastuzumab remains a major obstacle in HER2‐overexpressing breast cancer
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
[HTML][HTML] miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
H Tang, C Song, F Ye, G Gao, X Ou… - Journal of Cellular …, 2019 - ncbi.nlm.nih.gov
Resistance to trastuzumab remains a major obstacle in HER2‐overexpressing breast cancer
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
treatment. miR‐200c is important for many functions in cancer stem cells (CSCs), including …
miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
C Song, J Wang, H Wang, P Liu, L Liu, L Yang, H Tang… - bioRxiv, 2017 - biorxiv.org
Resistance to trastuzumab remains a major obstacle in HER2-overexpressing breast cancer
treatment. miR-200c is important for many functions in cancer stem cells (CSCs), including …
treatment. miR-200c is important for many functions in cancer stem cells (CSCs), including …
miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
H Tang, C Song, F Ye, G Gao, X Ou, L Zhang… - Journal of Cellular and …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Resistance to trastuzumab remains a major
obstacle in HER2‐overexpressing breast cancer treatment. miR‐200c is important for many …
obstacle in HER2‐overexpressing breast cancer treatment. miR‐200c is important for many …
miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
H Tang, C Song, F Ye, G Gao, X Ou… - Journal of cellular …, 2019 - pubmed.ncbi.nlm.nih.gov
Resistance to trastuzumab remains a major obstacle in HER2-overexpressing breast cancer
treatment. miR-200c is important for many functions in cancer stem cells (CSCs), including …
treatment. miR-200c is important for many functions in cancer stem cells (CSCs), including …
miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
C Song, J Wang, H Wang, P Liu, L Liu, L Yang, H Tang… - 2017 - europepmc.org
miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+
breast cancer - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
breast cancer - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …